The Precision Medicine Era PharmaVoice outlines why now is a new era of healthcare driven by precision medicine and how we got here, including the new trends in research to how we are moving these advancements out of research onto the market. Multiple leaders in...
Shifting Precision Medicine from Oncology to Autoimmune Diseases The Bio Report featured a podcast about precision medicine in autoimmune diseases and spoke with Alif Saleh, CEO of Scipher, to learn more about how we use gene expression data, instead of DNA, to...
Boston Business Journal highlights local companies advancing healthcare using AI Artificial intelligence is changing healthcare from how we diagnose diseases, model drug development, and predict response to therapies. The Boston Business Journal names Scipher Medicine...
Published by GenomeWeb Scipher Medicine of Boston is hoping to develop molecular signatures that can predict a patient’s response to autoimmune disease drugs, pushing precision medicine into areas other than oncology. The company, which was founded in 2014 by...
Even though there are several different therapies with different mechanism of actions, 91% of patients are prescribed anti‑TNF therapy as first-line biologic DMARD treatment Published in The Journal of Precision Medicine Authors: Keith Johnson, PhD and Michael...
